PPARG and malignant colon neoplasm: Activation of PPARγ by ligands such as troglitazone and 15-deoxy-Δ12,14 – prostaglandin J2 has been shown to down-regulate c-myc mRNA and protein expression in colon cancer cells and leukemic cell lines [34,35].